Development of vorinostat: Current applications and future perspectives for cancer therapy
Year: 2009
Type: review
Source: Cancer Letters
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2144991849
